tm logo
ORPHAZYME
Dead/Cancelled
CANCELLED – SECTION 71

on 25 Aug 2023

Last Applicant/ Owned by

Ole Maaløes Vej 3DK-2200 København N

DK

Serial Number

79180936 filed on 01st Dec 2015

Registration Number

5139414 registered on 14th Feb 2017

in the Principal Register

Correspondent Address

John Paul Oleksiuk

John Paul Oleksiuk Cooley LLP

Washington, DC 20004

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

ORPHAZYME

Industrial analysis and research services; basic research and clinical research, hereunder for medicine and vaccine development; all the aforementioned services with the exclusion of services relating to the veterinary sector Chemicals used in industry and in science; proteins for use in science and in manufacture; biochemicals, namely, polypeptides for scientific, research and commercial use; wi Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Industrial analysis and research services; basic research and clinical research, hereunder for medicine and vaccine development; all the aforementioned services with the exclusion of services relating to the veterinary sector


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical and medical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; chemical-pharmaceutical preparations for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; diagnostic preparations for medical purposes; reagents for medical purposes and for research; preparations for analysis for medical and research purposes for the treatment of rare and genetic diseases, for the treatment of diseases involving protein misfolding, for the treatment of diseases involving lysosomal pathology, for the treatment of disorders of the central nervous system, for the treatment of neurodegenerative diseases, for the treatment of neuropsychiatric disorders, for the treatment of movement disorders, for the treatment of parkinsonism and Parkinson's disease, for the treatment of Amyotrophic lateral sclerosis (ALS), motor neuron disease (MND) and Lysosomal storage diseases (LSD) and for the treatment of Niemann-Pick disease type C, for the treatment of diseases associated with dysregulation of cholesterol homeostasis, cholesterol trafficking, cholesterol metabolism and cholesterol biosynthesis and for the treatment of atherosclerosis; all of the aforementioned with the exclusion of veterinary preparations and ingredients, supplements for food, and medicated foodstuffs for animals


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Chemicals used in industry and in science; proteins for use in science and in manufacture; biochemicals, namely, polypeptides for scientific, research and commercial use; with the exclusion of chemicals used in the food industry and animal food industry and ingredients for foodstuffs for animals


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79180936

Mark Type

No Service Mark

Attorney Docket Number

No 336232-20024

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th May 2024TOTAL INVALIDATION PROCESSED BY THE IB
06th May 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06th May 2024INVALIDATION PROCESSED
25th Apr 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
25th Aug 2023CANCELLED SECTION 71
10th Jul 2022NEW REPRESENTATIVE AT IB RECEIVED
14th Feb 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12th Jun 2021NEW REPRESENTATIVE AT IB RECEIVED
08th Jun 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
08th Jun 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS